Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 18 studies | 29% ± 11% | |
| peripheral blood | 16 studies | 34% ± 8% | |
| brain | 13 studies | 30% ± 15% | |
| intestine | 8 studies | 27% ± 11% | |
| eye | 8 studies | 25% ± 9% | |
| kidney | 6 studies | 25% ± 9% | |
| lymph node | 5 studies | 31% ± 10% | |
| bone marrow | 4 studies | 34% ± 11% | |
| uterus | 4 studies | 36% ± 15% | |
| liver | 4 studies | 42% ± 13% | |
| adipose | 4 studies | 27% ± 5% | |
| pancreas | 3 studies | 36% ± 15% | |
| placenta | 3 studies | 27% ± 4% | |
| heart | 3 studies | 22% ± 2% | |
| breast | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 7324.26 | 1445 / 1445 | 100% | 50.73 | 183 / 183 |
| lung | 100% | 7976.16 | 578 / 578 | 99% | 39.42 | 1149 / 1155 |
| breast | 100% | 8698.97 | 459 / 459 | 99% | 58.83 | 1109 / 1118 |
| intestine | 100% | 8552.07 | 966 / 966 | 99% | 32.10 | 522 / 527 |
| bladder | 100% | 7672.81 | 21 / 21 | 99% | 35.07 | 499 / 504 |
| stomach | 100% | 6478.58 | 359 / 359 | 99% | 34.01 | 282 / 286 |
| thymus | 100% | 9749.94 | 653 / 653 | 98% | 37.21 | 595 / 605 |
| uterus | 100% | 8408.64 | 170 / 170 | 98% | 42.93 | 450 / 459 |
| prostate | 100% | 6629.98 | 245 / 245 | 98% | 31.89 | 492 / 502 |
| pancreas | 99% | 4292.50 | 325 / 328 | 99% | 34.14 | 176 / 178 |
| ovary | 100% | 8858.80 | 180 / 180 | 98% | 23.88 | 421 / 430 |
| brain | 99% | 3957.82 | 2605 / 2642 | 99% | 37.21 | 699 / 705 |
| skin | 100% | 10066.18 | 1809 / 1809 | 97% | 47.95 | 458 / 472 |
| kidney | 100% | 5244.40 | 89 / 89 | 94% | 27.76 | 851 / 901 |
| adrenal gland | 100% | 6826.76 | 258 / 258 | 91% | 22.90 | 210 / 230 |
| liver | 99% | 3170.81 | 224 / 226 | 87% | 20.76 | 354 / 406 |
| adipose | 100% | 9081.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 8732.94 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 36.17 | 29 / 29 |
| muscle | 100% | 5576.21 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 9086.04 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 12.69 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 41.81 | 44 / 45 |
| heart | 97% | 4521.90 | 832 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 93% | 6500.14 | 862 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 64% | 13.39 | 51 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0010793 | Biological process | regulation of mRNA export from nucleus |
| GO_0006405 | Biological process | RNA export from nucleus |
| GO_0046832 | Biological process | negative regulation of RNA export from nucleus |
| GO_0035457 | Biological process | cellular response to interferon-alpha |
| GO_0006611 | Biological process | protein export from nucleus |
| GO_0006999 | Biological process | nuclear pore organization |
| GO_0034605 | Biological process | cellular response to heat |
| GO_0070849 | Biological process | response to epidermal growth factor |
| GO_0031453 | Biological process | positive regulation of heterochromatin formation |
| GO_1901673 | Biological process | regulation of mitotic spindle assembly |
| GO_0032880 | Biological process | regulation of protein localization |
| GO_0042307 | Biological process | positive regulation of protein import into nucleus |
| GO_0046827 | Biological process | positive regulation of protein export from nucleus |
| GO_0051292 | Biological process | nuclear pore complex assembly |
| GO_0051301 | Biological process | cell division |
| GO_0031990 | Biological process | mRNA export from nucleus in response to heat stress |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006406 | Biological process | mRNA export from nucleus |
| GO_0043578 | Biological process | nuclear matrix organization |
| GO_0045947 | Biological process | negative regulation of translational initiation |
| GO_0006606 | Biological process | protein import into nucleus |
| GO_0090267 | Biological process | positive regulation of mitotic cell cycle spindle assembly checkpoint |
| GO_0010965 | Biological process | regulation of mitotic sister chromatid separation |
| GO_0006913 | Biological process | nucleocytoplasmic transport |
| GO_0007094 | Biological process | mitotic spindle assembly checkpoint signaling |
| GO_0046825 | Biological process | regulation of protein export from nucleus |
| GO_0090316 | Biological process | positive regulation of intracellular protein transport |
| GO_0006404 | Biological process | RNA import into nucleus |
| GO_0042306 | Biological process | regulation of protein import into nucleus |
| GO_0031647 | Biological process | regulation of protein stability |
| GO_0042405 | Cellular component | nuclear inclusion body |
| GO_0005643 | Cellular component | nuclear pore |
| GO_0072686 | Cellular component | mitotic spindle |
| GO_0000776 | Cellular component | kinetochore |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005868 | Cellular component | cytoplasmic dynein complex |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0044615 | Cellular component | nuclear pore nuclear basket |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0034399 | Cellular component | nuclear periphery |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0043495 | Molecular function | protein-membrane adaptor activity |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0015631 | Molecular function | tubulin binding |
| GO_0031072 | Molecular function | heat shock protein binding |
| GO_0017056 | Molecular function | structural constituent of nuclear pore |
| GO_0003729 | Molecular function | mRNA binding |
| GO_0051019 | Molecular function | mitogen-activated protein kinase binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0070840 | Molecular function | dynein complex binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TPR |
| Protein name | TPR protein Translocated promoter region, nuclear basket protein Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) |
| Synonyms | |
| Description | FUNCTION: Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs, plays a role in the establishment of nuclear-peripheral chromatin compartmentalization in interphase, and in the mitotic spindle checkpoint signaling during mitosis. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with NUP153, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Negatively regulates both the association of CTE-containing mRNA with large polyribosomes and translation initiation. Does not play any role in Rev response element (RRE)-mediated export of unspliced mRNAs. Implicated in nuclear export of mRNAs transcribed from heat shock gene promoters; associates both with chromatin in the HSP70 promoter and with mRNAs transcribed from this promoter under stress-induced conditions. Modulates the nucleocytoplasmic transport of activated MAPK1/ERK2 and huntingtin/HTT and may serve as a docking site for the XPO1/CRM1-mediated nuclear export complex. According to some authors, plays a limited role in the regulation of nuclear protein export . Also plays a role as a structural and functional element of the perinuclear chromatin distribution; involved in the formation and/or maintenance of NPC-associated perinuclear heterochromatin exclusion zones (HEZs). Finally, acts as a spatial regulator of the spindle-assembly checkpoint (SAC) response ensuring a timely and effective recruitment of spindle checkpoint proteins like MAD1L1 and MAD2L1 to unattached kinetochore during the metaphase-anaphase transition before chromosome congression. Its N-terminus is involved in activation of oncogenic kinases. . |
| Accessions | Q504U6 ENST00000613151.1 [P12270-2] A0PJC9 Q5SWX9 Q58F23 ENST00000451586.1 P12270 ENST00000367478.9 [P12270-1] Q9UE33 |